MEDTRONIC PUERTO RICO OPERATIONS CO. PERCEPT; STIMULATOR, ELECTRICAL, IMPLANTED, FOR PARKINS
|
Back to Search Results |
|
Model Number B35200 |
Device Problems
Break (1069); Intermittent Continuity (1121); Failure to Deliver Energy (1211); Inappropriate/Inadequate Shock/Stimulation (1574); Insufficient Information (3190); Patient Device Interaction Problem (4001)
|
Patient Problems
Dyskinesia (2363); Electric Shock (2554); Insufficient Information (4580)
|
Event Date 03/29/2023 |
Event Type
Injury
|
Event Description
|
It was reported that they think something has been wrong with the implantable neurostimulator (ins) ever since the patient had it im planted.The caller stated that the patient has been experiencing electrical shocks coming from the ins battery to the shoulder and up around the neck.The patient's neurosurgeon thought the electrical shocks were due to a pinched nerve, but results of x-ray, cat scan, and mri were negative for pinched nerve.The caller added that the patient continued to experience the electrical shocks after they decreased the ins settings.The caller also said that the patient goes into dyskinesia after they give the patient medicine.The caller stated that the patient has been digressing and experience "convulsion-type effects." the caller also stated that the neurologist told the patient that it looked like the ins was intermittently shutting itself off and restarting.The caller stated that the patient's neurosurgeon is considering giving the patient a steroid injection.The caller stated that the healthcare provider (hcp) told them there were no broken leads, and no evidence that there was anything wrong with the ins.The caller mentioned that an operating room nurse told them there could be a "leaky lead." the caller then stated that the patient has not had their head or chest area scanned yet.Agent did not ask about the circumstances that led to the reported issue.The patient was redirected to their hcp to further address the issue.The caller noticed that the dbs therapy app initially indicated that the patient's ins battery had more than 3 years remaining, then dropped to 2 years, then 3 years, and now it shows more than 4 years.Agent reviewed that the estimated time remaining depends on the last 7 days of ins usage/settings, which can cause the estimated time remaining to change.The caller understood.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
The manufacturer representative (rep) conferenced healthcare provider (hcp) onto the call.The dr reports that a couple months after the percept implant the patient (pt) started feeling electrical shocks in the implantable neurostimulator (ins) pocket and up the neck area.Pt reports the sensation comes and goes, but when he pushes on the ins he can feel the sensation.Dr reports the sensation is getting progressively worse.Dr reports there are now times where the pt loses therapy, or has abrupt off periods.Pocket revision surgery is scheduled for next friday.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information received from the manufacturer¿s representative (rep) reported surgery was scheduled for (b)(6).Further information would be available after this.
|
|
Event Description
|
Additional information received from the healthcare provider (hcp) the cause of the shocking wasn¿t determined.X-rays and a ct was performed to assess for lead fractures which was negative.They attempted to wean the patient off stimulation, but the patient was unable to tolerate this.The patient was scheduled for exploratory surgery on (b)(6) 2024.
|
|
Manufacturer Narrative
|
Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Event Description
|
Additional information received from the manufacturer¿s representative (rep), which was confirmed with the healthcare provider (hcp), reported surgery revealed an abnormality in one of the extensions.The surgeon chose to explant both extensions and the neurostimulator.After the extensions were replaced along with a rechargeable neurostimulator the patient was receiving regular therapy resolving the issue.
|
|
Manufacturer Narrative
|
Section d10 references: product id 3708660 serial# (b)(6) product type extension.Product id 3708660 serial# (b)(6) product type extension.Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
|
Manufacturer Narrative
|
Analysis results were not available at the time of this report.A follow-up report will be sent when analysis is completed.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
|
Event Description
|
Additional information received from the manufacturer¿s representative (rep) reported the extensions were replaced on (b)(6) 2024 as the patient was experiencing random shocking when turning their neck, lying in bed, and other random times.The rep wanted the lead analyzed for possible ¿electrical leakage¿ and a break.Following surgery the patient recovered without sequela.
|
|
Search Alerts/Recalls
|
|
|